665 related articles for article (PubMed ID: 29077259)
1. Autophagy promotes fibrosis and apoptosis in the peritoneum during long-term peritoneal dialysis.
Wu J; Xing C; Zhang L; Mao H; Chen X; Liang M; Wang F; Ren H; Cui H; Jiang A; Wang Z; Zou M; Ji Y
J Cell Mol Med; 2018 Feb; 22(2):1190-1201. PubMed ID: 29077259
[TBL] [Abstract][Full Text] [Related]
2. Parthenolide, an NF-κB inhibitor, alleviates peritoneal fibrosis by suppressing the TGF-β/Smad pathway.
Zhang Y; Huang Q; Chen Y; Peng X; Wang Y; Li S; Wu J; Luo C; Gong W; Yin B; Xiao J; Zhou W; Peng F; Long H
Int Immunopharmacol; 2020 Jan; 78():106064. PubMed ID: 31838448
[TBL] [Abstract][Full Text] [Related]
3. Histone acetyltransferase inhibitor C646 reverses epithelial to mesenchymal transition of human peritoneal mesothelial cells via blocking TGF-β1/Smad3 signaling pathway in vitro.
Yang Y; Liu K; Liang Y; Chen Y; Chen Y; Gong Y
Int J Clin Exp Pathol; 2015; 8(3):2746-54. PubMed ID: 26045780
[TBL] [Abstract][Full Text] [Related]
4. TGF-β1-VEGF-A pathway induces neoangiogenesis with peritoneal fibrosis in patients undergoing peritoneal dialysis.
Kariya T; Nishimura H; Mizuno M; Suzuki Y; Matsukawa Y; Sakata F; Maruyama S; Takei Y; Ito Y
Am J Physiol Renal Physiol; 2018 Feb; 314(2):F167-F180. PubMed ID: 28978530
[TBL] [Abstract][Full Text] [Related]
5. Network-based integrated analysis of omics data reveal novel players of TGF-β1-induced EMT in human peritoneal mesothelial cells.
Han SM; Ryu HM; Suh J; Lee KJ; Choi SY; Choi S; Kim YL; Huh JY; Ha H
Sci Rep; 2019 Feb; 9(1):1497. PubMed ID: 30728376
[TBL] [Abstract][Full Text] [Related]
6. MiR-200a negatively regulates TGF-β
Guo R; Hao G; Bao Y; Xiao J; Zhan X; Shi X; Luo L; Zhou J; Chen Q; Wei X
Am J Physiol Renal Physiol; 2018 Jun; 314(6):F1087-F1095. PubMed ID: 29357421
[TBL] [Abstract][Full Text] [Related]
7. Asiaticoside inhibits TGF-β1-induced mesothelial-mesenchymal transition and oxidative stress via the Nrf2/HO-1 signaling pathway in the human peritoneal mesothelial cell line HMrSV5.
Zhao J; Shi J; Shan Y; Yu M; Zhu X; Zhu Y; Liu L; Sheng M
Cell Mol Biol Lett; 2020; 25():33. PubMed ID: 32514269
[TBL] [Abstract][Full Text] [Related]
8. Empagliflozin, a sodium glucose cotransporter-2 inhibitor, ameliorates peritoneal fibrosis via suppressing TGF-β/Smad signaling.
Shentu Y; Li Y; Xie S; Jiang H; Sun S; Lin R; Chen C; Bai Y; Zhang Y; Zheng C; Zhou Y
Int Immunopharmacol; 2021 Apr; 93():107374. PubMed ID: 33517222
[TBL] [Abstract][Full Text] [Related]
9. Curcumin suppresses epithelial-to-mesenchymal transition of peritoneal mesothelial cells (HMrSV5) through regulation of transforming growth factor-activated kinase 1 (TAK1).
Zhao JL; Guo MZ; Zhu JJ; Zhang T; Min DY
Cell Mol Biol Lett; 2019; 24():32. PubMed ID: 31143210
[TBL] [Abstract][Full Text] [Related]
10. Nitro-oleic acid inhibits the high glucose-induced epithelial-mesenchymal transition in peritoneal mesothelial cells and attenuates peritoneal fibrosis.
Su W; Wang H; Feng Z; Sun J
Am J Physiol Renal Physiol; 2020 Feb; 318(2):F457-F467. PubMed ID: 31760768
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-302c modulates peritoneal dialysis-associated fibrosis by targeting connective tissue growth factor.
Li X; Liu H; Sun L; Zhou X; Yuan X; Chen Y; Liu F; Liu Y; Xiao L
J Cell Mol Med; 2019 Apr; 23(4):2372-2383. PubMed ID: 30693641
[TBL] [Abstract][Full Text] [Related]
12. Calcitriol decreases TGF-β1 and angiotensin II production and protects against chlorhexide digluconate-induced liver peritoneal fibrosis in rats.
Lee CJ; Subeq YM; Lee RP; Liou HH; Hsu BG
Cytokine; 2014 Jan; 65(1):105-18. PubMed ID: 24210651
[TBL] [Abstract][Full Text] [Related]
13. Paricalcitol ameliorates epithelial-to-mesenchymal transition in the peritoneal mesothelium.
Kang SH; Kim SO; Cho KH; Park JW; Yoon KW; Do JY
Nephron Exp Nephrol; 2014; 126(1):1-7. PubMed ID: 24458092
[TBL] [Abstract][Full Text] [Related]
14. Autophagy caused by oxidative stress promotes TGF-β1-induced epithelial-to-mesenchymal transition in human peritoneal mesothelial cells.
Oh SH; Yook JM; Jung HY; Choi JY; Cho JH; Park SH; Kim CD; Kim YL; Lim JH
Cell Death Dis; 2024 May; 15(5):365. PubMed ID: 38806451
[TBL] [Abstract][Full Text] [Related]
15. Blockade of thrombospondin-1 ameliorates high glucose-induced peritoneal fibrosis through downregulation of TGF-β1/Smad3 signaling pathway.
Jiang N; Zhang Z; Shao X; Jing R; Wang C; Fang W; Mou S; Ni Z
J Cell Physiol; 2020 Jan; 235(1):364-379. PubMed ID: 31236971
[TBL] [Abstract][Full Text] [Related]
16. Role of CIP4 in high glucose induced epithelial--mesenchymal transition of rat peritoneal mesothelial cells.
Zhang J; Bi M; Zhong F; Jiao X; Zhang D; Dong Q
Ren Fail; 2013 Aug; 35(7):989-95. PubMed ID: 23819628
[TBL] [Abstract][Full Text] [Related]
17. [High glucose dialysate enhances peritoneal fibrosis through upregulating glucose transporters GLUT1 and SGLT1].
Hong M; Nie Z; Chen Z; Yu X; Bao B
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2016 May; 45(6):598-606. PubMed ID: 28247603
[TBL] [Abstract][Full Text] [Related]
18. Paricalcitol attenuates TGF-β1-induced phenotype transition of human peritoneal mesothelial cells (HPMCs) via modulation of oxidative stress and NLRP3 inflammasome.
Ko J; Kang HJ; Kim DA; Ryu ES; Yu M; Lee H; Lee HK; Ryu HM; Park SH; Kim YL; Kang DH
FASEB J; 2019 Feb; 33(2):3035-3050. PubMed ID: 30354670
[TBL] [Abstract][Full Text] [Related]
19. Blocking TGF-β1 protects the peritoneal membrane from dialysate-induced damage.
Loureiro J; Aguilera A; Selgas R; Sandoval P; Albar-Vizcaíno P; Pérez-Lozano ML; Ruiz-Carpio V; Majano PL; Lamas S; Rodríguez-Pascual F; Borras-Cuesta F; Dotor J; López-Cabrera M
J Am Soc Nephrol; 2011 Sep; 22(9):1682-95. PubMed ID: 21742730
[TBL] [Abstract][Full Text] [Related]
20. A pathogenetic role for endothelin-1 in peritoneal dialysis-associated fibrosis.
Busnadiego O; Loureiro-Álvarez J; Sandoval P; Lagares D; Dotor J; Pérez-Lozano ML; López-Armada MJ; Lamas S; López-Cabrera M; Rodríguez-Pascual F
J Am Soc Nephrol; 2015 Jan; 26(1):173-82. PubMed ID: 25012164
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]